Gene · 10642
Papers3,895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,895
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The RNA-binding protein Imp1 promotes a Spdef transcriptional program and mucus fucosylation during necrotizing enterocolitis. | Am J Physiol Gastrointest Liver Physiol | 2026 | 42242905 | PubTator, text mining | PubMed |
| Master Regulator SMC1A, Stabilized by N6-Methyladenosine Reader IGF2BP1, Promotes HCC Progression Through Facilitating Enhancer-Promoter Interaction of Nestin. | Adv Sci (Weinh) | 2026 | 42170732 | PubTator, text mining | PubMed |
| Lnc RNA GAPLINC affects triple-negative breast cancer progression through the miR-331-3p/IGF2BP1 axis. | World J Surg Oncol | 2026 | 42152061 | PubTator, text mining | PubMed |
| PRMT3 in cancer: arginine methylation as a driver of tumor metabolism, immune evasion, and therapeutic resistance. | Front Immunol | 2026 | 42148077 | PubTator, text mining | PubMed |
| A Phosphorylation Switch Modulates Configurational Codes in the Oncofetal IGF2BP RNA Binding Paralogs. | bioRxiv | 2026 | 42146528 | PubTator, text mining | PubMed |
| PDE4D Mediates the Cardiac Ischemia Reperfusion Injury and Is m6A Modified by METTL14. | Korean Circ J | 2026 | 42144760 | PubTator, text mining | PubMed |
| Development of Water-Trapping Pyrrole-2-carboxylic Acids as Broad-Spectrum Metallo-β-lactamase Inhibitors. | J Med Chem | 2026 | 42133983 | PubTator, text mining | PubMed |
| Epidemiology and clinical outcomes of carbapenamase-producing organism (CPO) colonization: a tertiary care center experience in Saudi Arabia. | BMC Infect Dis | 2026 | 42129697 | PubTator, text mining | PubMed |
| KCTD10 weakens m6A modification of IL-11 in a ubiquitin-dependent manner to repress tumour immune escape in lung adenocarcinoma. | Br J Pharmacol | 2026 | 42107984 | PubTator, text mining | PubMed |
| IGF2BP1 promotes the malignant progression of laryngeal squamous cell carcinoma by activating the EMT pathway through m6A RNA methylation of C-MYC. | Int Immunopharmacol | 2026 | 42102605 | PubTator, text mining | PubMed |
| RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer. | Cancer Lett | 2026 | 42097492 | PubTator, text mining | PubMed |
| Phenotypic and genotypic characterization of HMB-3, a metallo-beta-lactamase from Pseudomonas asiatica. | J Antimicrob Chemother | 2026 | 42089879 | PubTator, text mining | PubMed |
| Molecular insights into DDX3X-androgen receptor mRNA regulation via non-canonical G-quadruplex in castration-resistant prostate cancer. | Oncogene | 2026 | 42082606 | PubTator, text mining | PubMed |
| Anticancer, antiapoptotic, and antimigratory effects of Enterococcus faecium-obtained postbiotics on colorectal cancer cells: In vitro studies. | Cancer Treat Res Commun | 2026 | 42019240 | PubTator, text mining | PubMed |
| PDK1 elevation was induced by epigenetic modifications of KDM3A and METTL16 to mediate TKI resistance and cancer development. | Genes Dis | 2026 | 42004224 | PubTator, text mining | PubMed |
| Characterizations of G-Quadruplex RNA-Protein Interactions in Living Cells. | Anal Chem | 2026 | 41996289 | PubTator, text mining | PubMed |
| RNA‑binding proteins as epithelial transcriptome orchestrators in gastric cancer: Immune‑metabolic crosstalk and therapeutic vulnerability (Review). | Int J Mol Med | 2026 | 41992985 | PubTator, text mining | PubMed |
| Targeting Ferroptosis With Natural Products for the Treatment of Skeletal System Disease: An Updated Review. | J Cell Mol Med | 2026 | 41928432 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
| METTL14 Promotes the Malignancy of Osteosarcoma by Mediating the m6A Methylation of ITGB3. | Ann Clin Lab Sci | 2026 | 41927113 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10642/papers?page=3